These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29119935)

  • 1. Perioperative Management of Hyperlipidemia Medications.
    Renew JR
    Curr Clin Pharmacol; 2017; 12(3):152-156. PubMed ID: 29119935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of lipid-lowering therapies.
    Davidson MH; Toth PP
    Prog Cardiovasc Dis; 2004; 47(2):73-104. PubMed ID: 15586350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
    Margaritis M; Antoniades C
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521
    [No Abstract]   [Full Text] [Related]  

  • 4. Perioperative statin therapy reduces mortality in normolipidemic patients undergoing cardiac surgery.
    Vaduganathan M; Stone NJ; Lee R; McGee EC; Malaisrie SC; Silverberg RA; Kansal P; McCarthy PM
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1018-27. PubMed ID: 20851427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
    Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipids--Diagnosis and therapy in diabetes mellitus].
    Wascher TC; Paulweber B; Toplak H; Säly CH; Drexel H; Föger B; Hoppichler F
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S68-70. PubMed ID: 27052223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing hyperlipidemia: current and future roles of HMG-CoA reductase inhibitors.
    Lopez LM
    Am J Health Syst Pharm; 2002 Jun; 59(12):1173-9; quiz 1180-2. PubMed ID: 12073858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective case series of the lipid effects of switching from omega-3 fatty acid ethyl esters to icosapent ethyl in hyperlipidemic patients.
    Castaldo RS
    Postgrad Med; 2014 May; 126(3):268-73. PubMed ID: 24977343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative Pulmonary Medication Management.
    Renew JR; Aniskevich S
    Curr Clin Pharmacol; 2017; 12(3):182-187. PubMed ID: 28925861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined treatment: regimens, indications and safety profile].
    Muñiz Grijalvo O; Villar Ortiz J
    Clin Investig Arterioscler; 2013; 25(3):140-5. PubMed ID: 23880257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of intake of lipid lowering drugs: is that of importance?
    Hanefeld M
    Klin Wochenschr; 1989 May; 67(9):511-2. PubMed ID: 2733381
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of perioperative statin therapy for noncardiac surgery.
    Skrlin S; Hou V
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):283-90. PubMed ID: 21041202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse effects of lipid-lowering medications].
    Fukumoto Y; Shimokawa H
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():165-72. PubMed ID: 18074533
    [No Abstract]   [Full Text] [Related]  

  • 15. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia.
    Micallef MA; Garg ML
    J Nutr Biochem; 2009 Dec; 20(12):927-39. PubMed ID: 19733044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niacin as a component of combination therapy for dyslipidemia.
    Miller M
    Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia.
    McCrindle BW; Helden E; Cullen-Dean G; Conner WT
    Pediatr Res; 2002 Jun; 51(6):715-21. PubMed ID: 12032266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering drugs.
    Milander MM; Kuhn M
    AACN Clin Issues Crit Care Nurs; 1992 May; 3(2):494-506. PubMed ID: 1576043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statins (HMG-CoA reductase inhibitors)].
    Gotoda T
    Nihon Rinsho; 2006 Nov; 64(11):2113-8. PubMed ID: 17087305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.